Evaluating Patient Reported Outcomes in Radiation Therapy, the PRO-RT Study

Mayo Clinic

Status: Completed

Conditions: Head and Neck Carcinoma; Lung Carcinoma; Malignant Solid Neoplasm; Breast Carcinoma

Treatments: Other: Medical Device Usage and Evaluation; Other: Electronic Health Record Review; Other: Survey Administration

Study type: Observational

Funder types: Other; NIH

Identifiers

NCT05224271

21-003294 (Other Identifier)

NCI-2021-12580 (Registry Identifier)

ROR2103 (Other Identifier)

Details and patient eligibility

About

This study explores the use of the Hugo platform to involve study participants in their healthcare and treatments. The Hugo platform may allow researchers to collect better and more accurate real-time health data, from other clinics/hospitals, pharmacies and other electronic devices. The purpose of this research is to see if the use of the Hugo platform is consistent, accurate, cost effective, and time efficient, as it collects and transmits important real-time health information from other clinics/hospitals, pharmacies, and other electronic devices.

Full description

PRIMARY OBJECTIVES:

I. Evaluate the data aggregation from a patient centered platform over a follow up period for completeness and quality, including externally linked electronic health record (EHR) information, toxicity completion, and the patient reported outcomes (PRO) response rates for study patients, compared with historical pre-coronavirus disease (COVID) cohort of registry patients.

II. To explore biometric information obtained from wearables as it pertains to the toxicity of treatment for patients using a wearable device.

III. To estimate app-based survey completion rates using Hugo-based survey incentive completion (gift cards).

IV. To explore the cost data available on the platform.

OUTLINE:

Patients complete surveys via the Hugo Platform at baseline (before treatment), after treatment, and at 3 and 6 months after treatment. Patients' medical records and Fitbit information are also collected into the Hugo Platform.

Enrollment: 18 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age 18+
• English speaking
• Consented for Outcomes Registry Study (15-000136)
• Undergoing radiotherapy for cancer treatment with curative intent
• Willing to and able to give consent and participate in study
• Willing to complete all surveys
• Able to access a device (computer, smartphone, or tablet) with web access every day to complete study surveys
• Willing to connect to a device (i.e., a smartphone, Fitbit, or tablet) that can regularly link to Hugo for data transfer
• Willing to share personal information to Tremendous to be able to obtain the Visa e-cards for time and effort put into this study
• Willing to use the Hugo health data sharing platform
• Willing to create a Mayo Clinic Patient Portal (if not already created)

Exclusion criteria

• Unable to give consent and enroll prior to administration of baseline survey

• Partial breast radiation therapy (RT) (3 fraction), due to overlap in cadence used for all disease sites

• Stereotactic body radiation therapy (SBRT) to the lung, due to overlap in cadence used for all disease sites

• Co-enrollment on another PRO related study (soft rule)

  • Coordinator would need to get source data from Adam via Hugo
  • Response data will only be accessible by select people

Trial design

18 participants in 1 patient group

Observational (surveys, medical records & Fitbit collection)

Description:

Patients complete surveys via the Hugo Platform at baseline (before treatment), after treatment, and at 3 and 6 months after treatment. Patients' medical records and Fitbit information are also collected into the Hugo Platform.

Treatment:

Other: Survey Administration

Other: Electronic Health Record Review

Other: Medical Device Usage and Evaluation